Obamacare is going to kill traditional employer-provided insurance. And that's probably a good thing.
Obamacare is going to kill traditional employer-provided insurance. And that’s probably a good thing. IBM, Time Warner, and now Walgreens have made headlines over the past two weeks by announcing that they plan to move retirees (IBM, Time Warner) and current employees (Walgreens) into private health insurance exchanges with defined contributions from employers.
Retiree health benefits—like lifetime pensions—have been shrinking in the private sector for decades (only about half of large employers still offer them, down from 80 percent 20 years ago), so it’s no surprise that the relatively few companies like IBM that do offer generous post-retirement health benefits are trying to find ways to keep them affordable.
Private Medicare exchanges are relatively well established at this point, so what is surprising is how quickly private insurance exchanges for current employees are attracting interest from employers. A recent survey by Accenture suggests that while Obamacare’s publicly funded exchanges will enroll more people at first, by 2018 more people will be enrolled in private exchanges (40 million) than the public exchanges (31 million). Accenture also reports that more than 1 in 4 employers are considering moving their employees to a private exchange format over the next 3 to 5 years.
Read the full story here: http://onforb.es/19vFngA
Source: Forbes
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More